APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β

Research output: Contribution to journal › Editorial › Academic › peer-review

Access to Document

@article{36f3a007c24944508546a898157137e8,

title = "APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β",

author = "Rik Ossenkoppele and {van der Flier}, {Wiesje M.}",

year = "2023",

month = dec,

day = "11",

doi = "10.1001/jamaneurol.2023.4046",

language = "English",

volume = "80",

pages = "1269--1271",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β

AU - Ossenkoppele, Rik

AU - van der Flier, Wiesje M.

PY - 2023/12/11

Y1 - 2023/12/11

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85179680245&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/37930662

U2 - 10.1001/jamaneurol.2023.4046

DO - 10.1001/jamaneurol.2023.4046

M3 - Editorial

C2 - 37930662

SN - 2168-6149

VL - 80

SP - 1269

EP - 1271

JO - JAMA Neurology

JF - JAMA Neurology

IS - 12

ER -